Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Parkwalk Advisors manages over £500m in assets and has invested in more than 200 UK university spinouts across deeptech sectors including life sciences, genomics, medtech, AI, materials science. It provides early-stage growth capital with a strong track record of exits. Its investments have enabled the development of novel gene therapies for eye diseases, next-generation antibody-drug conjugates for cancer treatment, digital health platforms for diagnostics and monitoring neurological conditions among others.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Parkwalk Advisors.